Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results

Autologous adipose-derived stromal cell treatment for patients with refractory angina (MyStromalCell Trial): 3-years follow-up results

Abstract Background Stem cell therapy is investigated as a treatment option for patients with ischemic heart disease. In this study, long-term safety and efficacy of autologous intra-myocardial injections of adipose-derived stromal cells (ASCs) was studied in patients with refractory angina. Methods...

Full description

Bibliographic Details
Main Authors: Abbas Ali Qayyum, Anders Bruun Mathiasen, Steffen Helqvist, Erik Jørgensen, Mandana Haack-Sørensen, Annette Ekblond, Jens Kastrup
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Journal of Translational Medicine
Subjects:
Adipose derived stromal cells
Chronic ischemic heart disease
Regeneration
Stem cell therapy
Refractory angina
Online Access:http://link.springer.com/article/10.1186/s12967-019-2110-1

Internet

http://link.springer.com/article/10.1186/s12967-019-2110-1

Similar Items